12:00 AM
Jan 23, 2012
 |  BC Week In Review  |  Company News  |  Deals

Vivalis, Sanofi deal

Vivalis and Sanofi Pasteur, the vaccines division of Sanofi, added an additional undisclosed infectious disease target to a June 2010 deal under which the division gained exclusive access to Vivalis' VIVA|Screen technology to discover...

Read the full 148 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >